Literature DB >> 23846495

Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells.

Nwe Nwe Soe1, Mark Sowden, Padmamalini Baskaran, Elaine M Smolock, Yeonghwan Kim, Patrizia Nigro, Bradford C Berk.   

Abstract

OBJECTIVE: Angiotensin II (AngII) signal transduction in vascular smooth muscle cells (VSMC) is mediated by reactive oxygen species (ROS). Cyclophilin A (CyPA) is a ubiquitously expressed cytosolic protein that possesses peptidyl-prolyl cis-trans isomerase activity, scaffold function, and significantly enhances AngII-induced ROS production in VSMC. We hypothesized that CyPA regulates AngII-induced ROS generation by promoting translocation of NADPH oxidase cytosolic subunit p47phox to caveolae of the plasma membrane. APPROACH AND
RESULTS: Overexpression of CyPA in CyPA-deficient VSMC (CyPA(-/-)VSMC) significantly increased AngII-stimulated ROS production. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitors (VAS2870 or diphenylene iodonium) significantly attenuated AngII-induced ROS production in CyPA and p47phox-overexpressing CyPA(-/-)VSMC. Cell fractionation and sucrose gradient analyses showed that AngII-induced p47phox plasma membrane translocation, specifically to the caveolae, was reduced in CyPA(-/-)VSMC compared with wild-type-VSMC. Immunofluorescence studies demonstrated that AngII increased p47phox and CyPA colocalization and translocation to the plasma membrane. In addition, immunoprecipitation of CyPA followed by immunoblotting of p47phox and actin showed that AngII increased CyPA and p47phox interaction. AngII-induced p47phox and actin cell cytoskeleton association was attenuated in CyPA(-/-)VSMC. Mechanistically, inhibition of p47phox phosphorylation and phox homology domain deletion attenuated CyPA and p47phox interaction. Finally, cyclosporine A and CyPA-peptidyl-prolyl cis-trans isomerase mutant, R55A, inhibited AngII-stimulated CyPA and p47phox association in VSMC, suggesting that peptidyl-prolyl cis-trans isomerase activity was required for their interaction.
CONCLUSIONS: These findings provide the mechanism by which CyPA is an important regulator for AngII-induced ROS generation in VSMC through interaction with p47phox and cell cytoskeleton, which enhances the translocation of p47phox to caveolae.

Entities:  

Keywords:  angiotensin II; cyclophilin A; cytoskeleton; p47phox protein, mouse; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 23846495      PMCID: PMC3817838          DOI: 10.1161/ATVBAHA.113.301894

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

1.  The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells.

Authors:  Junya Kuroda; Kazunori Nakagawa; Tomoko Yamasaki; Kei-ichiro Nakamura; Ryu Takeya; Futoshi Kuribayashi; Shinobu Imajoh-Ohmi; Kazuhiko Igarashi; Yosaburo Shibata; Katsuo Sueishi; Hideki Sumimoto
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

Review 2.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

3.  p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.

Authors:  R M Touyz; G Yao; M T Quinn; P J Pagano; E L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-12-23       Impact factor: 8.311

Review 4.  Localizing NADPH oxidase-derived ROS.

Authors:  Masuko Ushio-Fukai
Journal:  Sci STKE       Date:  2006-08-22

5.  Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1.

Authors:  Ru Feng Wu; Ying Gu; You Cheng Xu; Fiemu E Nwariaku; Lance S Terada
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

6.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

7.  Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages.

Authors:  U Krummrei; R Bang; R Schmidtchen; K Brune; H Bang
Journal:  FEBS Lett       Date:  1995-08-28       Impact factor: 4.124

Review 8.  Reactive oxygen species in the vasculature: molecular and cellular mechanisms.

Authors:  Yoshihiro Taniyama; Kathy K Griendling
Journal:  Hypertension       Date:  2003-10-27       Impact factor: 10.190

9.  Cyclophilin A cooperates with MIP-2 to augment neutrophil migration.

Authors:  Shannon J Heine; Denise Olive; Ji-Liang Gao; Philip M Murphy; Michael I Bukrinsky; Stephanie L Constant
Journal:  J Inflamm Res       Date:  2011-06-03

10.  Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms.

Authors:  Kimio Satoh; Patrizia Nigro; Tetsuya Matoba; Michael R O'Dell; Zhaoqiang Cui; Xi Shi; Amy Mohan; Chen Yan; Jun-ichi Abe; Karl A Illig; Bradford C Berk
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

View more
  13 in total

Review 1.  Redox regulation of vascular remodeling.

Authors:  Keyvan Karimi Galougahi; Euan A Ashley; Ziad A Ali
Journal:  Cell Mol Life Sci       Date:  2015-10-20       Impact factor: 9.261

Review 2.  Extracellular and Intracellular Cyclophilin A, Native and Post-Translationally Modified, Show Diverse and Specific Pathological Roles in Diseases.

Authors:  Chao Xue; Mark P Sowden; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-29       Impact factor: 8.311

Review 3.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Expression and significance of cortactin and HDAC6 in human prostatic foamy gland carcinoma.

Authors:  Huilian Hou; Le Zhao; Wei Chen; Jing Li; Qinqin Zuo; Guanjun Zhang; Xuebin Zhang; Xu Li
Journal:  Int J Exp Pathol       Date:  2015-06-26       Impact factor: 1.925

5.  Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.

Authors:  Chao Xue; Mark Sowden; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-27       Impact factor: 8.311

6.  Human serum albumin and oxidative stress in preeclamptic women and the mechanism of albumin for stress reduction.

Authors:  Hiroyuki Kinoshita; Kazushi Watanabe; Toshiharu Azma; Guo-Gang Feng; Takahiko Akahori; Hisaki Hayashi; Motohiko Sato; Yoshihiro Fujiwara; Akihiko Wakatsuki
Journal:  Heliyon       Date:  2017-08-02

Review 7.  Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.

Authors:  Giona Sonego; Mélanie Abonnenc; Jean-Daniel Tissot; Michel Prudent; Niels Lion
Journal:  Int J Mol Sci       Date:  2017-02-11       Impact factor: 5.923

8.  Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth.

Authors:  Gregory Pedroso Dos Santos; Fernanda Midori Abukawa; Normanda Souza-Melo; Laura Maria Alcântara; Paula Bittencourt-Cunha; Carolina Borsoi Moraes; Bijay Kumar Jha; Bradford S McGwire; Nilmar Silvio Moretti; Sergio Schenkman
Journal:  Cell Microbiol       Date:  2020-12-09       Impact factor: 3.715

9.  CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.

Authors:  Yuefeng Li; Jinchuan Yan; Chao Wu; Zhongqun Wang; Wei Yuan; Dongqing Wang
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

Review 10.  Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.

Authors:  Saskia N I von Ungern-Sternberg; Alma Zernecke; Peter Seizer
Journal:  Int J Mol Sci       Date:  2018-02-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.